Humana (HUM) Stock Forecast & Price Target

Compare

2,683 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HUM Analyst Ratings

Hold

4 Buy

7 Hold

1 Sell

Based on 12 analysts giving stock ratings to

Humana

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HUM Stock 12 Month Forecast

Average Price Target

$279.44

▲(47.47% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $279.44 with a high forecast of $344.00 and a low forecast of $174.00. The average price target represents a 47.47% change from the last price of $189.49.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"173":"$173","216":"$216","259":"$259","302":"$302","345":"$345"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":344,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$344.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":279.44,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$279.44</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":174,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$174.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[173,216,259,302,345],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,187.2,199.26153846153846,211.3230769230769,223.3846153846154,235.44615384615383,247.5076923076923,259.5692307692308,271.63076923076926,283.6923076923077,295.75384615384615,307.81538461538463,319.87692307692305,331.9384615384615,{"y":344,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,187.2,194.2953846153846,201.39076923076922,208.48615384615383,215.58153846153846,222.67692307692306,229.7723076923077,236.8676923076923,243.96307692307693,251.05846153846153,258.15384615384613,265.24923076923073,272.3446153846154,{"y":279.44,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,187.2,186.18461538461537,185.16923076923075,184.15384615384613,183.13846153846154,182.12307692307692,181.1076923076923,180.09230769230768,179.07692307692307,178.06153846153845,177.04615384615386,176.03076923076924,175.01538461538462,{"y":174,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":289.19,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":266.69,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":261.95,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":253.34,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":228.95,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":250.84,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":245.56,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":307.93,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":245.93,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":277.24,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":241.4,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":256.13,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":187.2,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$344.00

Average Price Target$279.44

Lowest Price Target$174.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Elizabeth Anderson CFA

Evercore ISI

$260

Hold

37.21%

Upside

Reiterated

02/09/26

Evercore ISI Sticks to Their Hold Rating for Humana (HUM)

Erin Wright

Morgan Stanley

$262→$174

Sell

-8.17%

Downside

Downgraded

02/02/26

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (NYSE: DGX), Synergy CHC (NASDAQ: SNYR) and Humana (NYSE: HUM)

David S Macdonald

Truist Financial

Hold

―

Reiterated

01/27/26

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), MannKind (NASDAQ: MNKD) and Inspire Medical Systems (NYSE: INSP)

Kevin Fischbeck

Bank of America Securities

$300→$260

Hold

37.21%

Upside

Reiterated

01/27/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (NYSE: LLY), West Pharmaceutical Services (NYSE: WST) and Humana (NYSE: HUM)

Lance Wilkes

Bernstein

$344

Buy

81.54%

Upside

Reiterated

01/27/26

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), Certara (NASDAQ: CERT) and Edgewise Therapeutics (NASDAQ: EWTX)

David Windley

Jefferies

$313→$310

Buy

63.60%

Upside

Reiterated

01/26/26

Analysts Are Bullish on Top Healthcare Stocks: Humana (HUM), Praxis Precision Medicines (PRAX)

Ben Hendrix

RBC Capital

$322

Buy

69.93%

Upside

Reiterated

01/22/26

RBC Capital Sticks to Their Buy Rating for Humana (HUM)

Ann Hynes

Mizuho Securities

$310

Buy

63.60%

Upside

Reiterated

01/15/26

Humana (HUM) Gets a Buy from Mizuho Securities

Stephen Baxter

Wells Fargo

$290

Hold

53.04%

Upside

Downgraded

01/07/26

Humana downgraded to Equal Weight from Overweight at Wells FargoHumana downgraded to Equal Weight from Overweight at Wells Fargo

Andrew Mok CFA

Barclays

$234→$245

Hold

29.29%

Upside

Reiterated

01/05/26

Humana price target raised to $245 from $234 at BarclaysHumana price target raised to $245 from $234 at Barclays

Matthew Gillmor CFA

KeyBanc

Hold

―

Reiterated

12/12/25

Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and Humana (NYSE: HUM)

David Toung

Argus Research

Hold

―

Reiterated

12/08/25

Humana seeking path to higher profitability, says ArgusHumana seeking path to higher profitability, says Argus

George Hill

Deutsche Bank

$250→$231

Hold

21.91%

Upside

Reiterated

11/07/25

Humana price target lowered to $231 from $250 at Deutsche BankHumana price target lowered to $231 from $250 at Deutsche Bank

Michael Wiederhorn

Oppenheimer

$310

Buy

63.60%

Upside

Reiterated

11/06/25

Oppenheimer Remains a Buy on Humana (HUM)

Ryan Langston

TD Cowen

$260

Hold

37.21%

Upside

Reiterated

11/06/25

Humana's Hold Rating: Balancing Positive Earnings with Strategic Challenges

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Elizabeth Anderson CFA

Evercore ISI

$260

Hold

37.21%

Upside

Reiterated

02/09/26

Evercore ISI Sticks to Their Hold Rating for Humana (HUM)

Erin Wright

Morgan Stanley

$262→$174

Sell

-8.17%

Downside

Downgraded

02/02/26

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (NYSE: DGX), Synergy CHC (NASDAQ: SNYR) and Humana (NYSE: HUM)

David S Macdonald

Truist Financial

Hold

―

Reiterated

01/27/26

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), MannKind (NASDAQ: MNKD) and Inspire Medical Systems (NYSE: INSP)

Kevin Fischbeck

Bank of America Securities

$300→$260

Hold

37.21%

Upside

Reiterated

01/27/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (NYSE: LLY), West Pharmaceutical Services (NYSE: WST) and Humana (NYSE: HUM)

Lance Wilkes

Bernstein

$344

Buy

81.54%

Upside

Reiterated

01/27/26

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), Certara (NASDAQ: CERT) and Edgewise Therapeutics (NASDAQ: EWTX)

David Windley

Jefferies

$313→$310

Buy

63.60%

Upside

Reiterated

01/26/26

Analysts Are Bullish on Top Healthcare Stocks: Humana (HUM), Praxis Precision Medicines (PRAX)

Ben Hendrix

RBC Capital

$322

Buy

69.93%

Upside

Reiterated

01/22/26

RBC Capital Sticks to Their Buy Rating for Humana (HUM)

Ann Hynes

Mizuho Securities

$310

Buy

63.60%

Upside

Reiterated

01/15/26

Humana (HUM) Gets a Buy from Mizuho Securities

Stephen Baxter

Wells Fargo

$290

Hold

53.04%

Upside

Downgraded

01/07/26

Humana downgraded to Equal Weight from Overweight at Wells FargoHumana downgraded to Equal Weight from Overweight at Wells Fargo

Andrew Mok CFA

Barclays

$234→$245

Hold

29.29%

Upside

Reiterated

01/05/26

Humana price target raised to $245 from $234 at BarclaysHumana price target raised to $245 from $234 at Barclays

Matthew Gillmor CFA

KeyBanc

Hold

―

Reiterated

12/12/25

Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and Humana (NYSE: HUM)

David Toung

Argus Research

Hold

―

Reiterated

12/08/25

Humana seeking path to higher profitability, says ArgusHumana seeking path to higher profitability, says Argus

George Hill

Deutsche Bank

$250→$231

Hold

21.91%

Upside

Reiterated

11/07/25

Humana price target lowered to $231 from $250 at Deutsche BankHumana price target lowered to $231 from $250 at Deutsche Bank

Michael Wiederhorn

Oppenheimer

$310

Buy

63.60%

Upside

Reiterated

11/06/25

Oppenheimer Remains a Buy on Humana (HUM)

Ryan Langston

TD Cowen

$260

Hold

37.21%

Upside

Reiterated

11/06/25

Humana's Hold Rating: Balancing Positive Earnings with Strategic Challenges

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Humana

3 Months

xxx

Success Rate

26/40 ratings generated profit

Average Return

+1.55%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 65.00% of your transactions generating a profit, with an average return of +1.55% per trade.

1 Year

Michael WiederhornOppenheimer

Success Rate

22/40 ratings generated profit

Average Return

+1.34%

a rating ―

Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 55.00% of your transactions generating a profit, with an average return of +1.34% per trade.

2 Years

xxx

Success Rate

26/40 ratings generated profit

Average Return

+5.58%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 65.00% of your transactions generating a profit, with an average return of +5.58% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HUM Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HUM has received 10 Buy Ratings, 9 Hold Ratings, and 1 Sell Ratings. HUM average Analyst price target in the past 3 months is 279.44.

Each month's total comprises the sum of three months' worth of ratings.

HUM Financial Forecast

HUM Earnings Forecast

Currently, no earnings data available.

HUM Sales Forecast

Currently, no sales data available.

HUM Stock Forecast FAQ

What is HUM’s average 12-month price target, according to analysts?

Based on analyst ratings, Humana Inc’s 12-month average price target is 279.44.

What is HUM’s upside potential, based on the analysts’ average price target?

Humana Inc has 47.47% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HUM a Buy, Sell or Hold?

Humana Inc has a consensus rating of Hold which is based on 4 buy ratings, 7 hold ratings and 1 sell ratings.

What is Humana Inc’s price target?

The average price target for Humana Inc is 279.44. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $344.00 ,the lowest forecast is $174.00. The average price target represents 47.47% Increase from the current price of $189.49.

What do analysts say about Humana Inc?

Humana Inc’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of HUM?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Humana (HUM) Stock Forecast & Price Target

HUM Analyst Ratings

HUM Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Humana

HUM Analyst Recommendation Trends

HUM Financial Forecast

HUM Earnings Forecast

HUM Sales Forecast

HUM Stock Forecast FAQ

Detailed List of Analyst Forecasts